coronary heart disease
Conditions
Interventions
control group:placebo
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. A total of 60 patients with coronary heart disease, coronary CT suggests coronary atherosclerotic narrowing by 50-70%, the plaque belongs to soft plaque or mixed plaque, without PCI or bypass surgery, syndrome differentiation of TCM belongs to Phlegm Stasis Syndrome; 2. Aged 18-80 years; 3. Living in lingnan region for a long time (Live for no less than 3 years, no less than 9 months per year); 4. Informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with malignant tumor diseases; 2. The patient is younger than 18 years old, more than 80 years old. Pregnant women, lactating women. People who are allergic to Chinese medicine; 3. In combination of severe infection, or serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system. Patients with mental disorders or cognitive dysfunction; 4. People with congenital metabolic abnormalities or immune diseases; 5. Take other medications, or combine other chronic diseases with drug therapy; 6. Patients who are with bad compliance, not able to be interviewed regularly; 7. Participated in other clinical trials in the last 3 months; 8. Other situations that the researchers consider not fit for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coronary CT; | — |
Secondary
| Measure | Time frame |
|---|---|
| ABCA1 and related factor concentrations;CRP;Blood Lipid;Standards of TCM symptoms;Quality of life;Safety Evaluation;MACE; | — |
Countries
China
Contacts
Public ContactDanping Xu
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed